Pharmacokinetics of bicyclol in rats with acute hepatic failure

References

• Bruno B, Nicole LT, Rachid B, Michel MT. In vitro metabolism and drug interaction potential of a new highly potent anti-cytomegalovirus molecule, CMV423 (2-chloro 3-pyridine 3-yl 5,6,7,8-tetrahydroindolizine 1-carboxamide). British Journal of Clinical Pharmacology 2001; 52: 53–63
   PubMedGoogle Scholar
• Castilla C, Prieto J, Urdaneta E, Pascual M, Nuñez M, Zudaire E, Garcia M, Quiroga J, Santidrian S. Impaired intestinal sugar transport in cirrhotic rats: Correction by low doses of insulin-like growth factor I. Gastroenterology 1997; 113: 1180–1187
   PubMedGoogle Scholar
• Cummins CL, Salphati L, Reid MJ, Benet LZ. In vivo modulation of intestinal CYP3A metabolism by P-glycoprotein: Studies using the rat single-pass intestinal perfusion model. Journal of Pharmacology and Experimental Therapy 2003; 305: 306–314
   PubMed Web of Science ®Google Scholar
• Hu QW, Liu GT. Effects of bicyclol on dimethylnitrosamine-induced liver fibrosis in mice and its mechanism of action. Life Science 2006; 79: 606–612
   PubMed Web of Science ®Google Scholar
• Huang ZH, Murakami T, Okochi A, Yumoyo R, Nagai J, Takano M. Expression and function of P-glycoprotein in rats with carbon tetrachloride-induced acute hepatic failure. Journal of Pharmacy and Pharmacology 2001; 53: 873–881
   PubMed Web of Science ®Google Scholar
• Johnson BM, Chen WQ, Borchardt RT, Charman WN, Porter CJH. A kinetic evaluation of the absorption, efflux, and metabolism of verapamil in the autoperfused rat jejunum. Journal of Pharmacology and Experimental Therapeutics 2003; 305: 151–158
   PubMed Web of Science ®Google Scholar
• Ju MH, Li Y. Metabolism of bicyclol in rat and human liver microsomes in vitro. Acta Pharmaceutica Sinica 2005; 2: 111–116
   Google Scholar
• Li C, Nakayama S, Kurosaki Y, Nakayama T, Kimura T. Pharmacokinetics of cefpiramide in rats acutely intoxicated with carbon tetrachloride. Journal of Pharmacobio-dynamics 1990; 13: 186–194
   PubMedGoogle Scholar
• Li Y, Li Y, Liu GT. Protective effects of bicyclol on liver fibrosis induced by carbon tetrachloride. Chinese Medical Journal 2004; 84: 2096–2101
   Google Scholar
• Liu GT. The anti-virus and hepatoprotective effect of bicyclol and its mechanism of action. Chinese Journal of New Drugs 2001; 10: 325–327
   Google Scholar
• Mahnaz S, Andrew H, Glen BB. Inhibitory effects of the monoamine oxidase inhibitor tranylcypromine on the cytochrome P450 enzymes CYP2C19, CYP2C9, and CYP2D6. Cellular and Molecular Neurobiology 2004; 24: 63–76
   PubMedGoogle Scholar
• Okumura H, Katoh M, Minami K, Nakajima M, Yokoi T. Change of drug excretory pathway by CCl4-induced liver dysfunction in rat. Biochemical Pharmacology 2007; 74: 488–495
   PubMed Web of Science ®Google Scholar
• McLean AJ, Morgan DJ. Clinical pharmacokinetics in patients with liver disease. Clinical Pharmacokinetics 1991; 21: 42–69
   PubMed Web of Science ®Google Scholar
• Minami K, Saito T, Narahara M, Tomita H, Kato H, Sugiyama H. Relationship between hepatic gene expression profiles and hepatotoxicity in five typical hepatotoxicant administered rats. Toxicology Science 2005; 87: 296–305
   PubMed Web of Science ®Google Scholar
• Okumura H, Katah M, Minami K, Nakajima M, Yokoi T. Change of drug excretory pathway by ccl4-induced liver dysfunction in rat. Biochemical Pharmacology 2007; 74: 488–495
   PubMed Web of Science ®Google Scholar
• Park EJ, Jeon CH, Ko G, Kim J, Sohn DH. Protective effect of curcumin in rat liver injury induced by carbon tetrachloride. Journal of Pharmacy and Pharmacology 2000; 52: 437–440
   PubMed Web of Science ®Google Scholar
• Reza M, Anjaneya PC. Hepatic disposition of cyclosporine A in isolated perfused rat livers. Journal of Pharmaceutical Sciences 2004; 7: 47–54
   Google Scholar
• Savina PM, Staubus AE, Gaginella TS, Smith DF. Optimal perfusion rate determined for in situ intestinal absorption studies in rats. Journal of Pharmaceutical Sciences 1981; 70: 239–243
   PubMed Web of Science ®Google Scholar
• Singhal D, Ho NF, Anderson BD. Absorption and intestinal metabolism of purine dideoxynucleosides and an adenosine deaminase-activated prodrug of 2′,3′-dideoxyinosine in the mesenteric vein cannulated rat ileum. Journal of Pharmaceutical Sciences 1998; 87: 569–577
   PubMed Web of Science ®Google Scholar
• Sugano T, Suda K, Shimada M, Oshino N. Biochemical and ultrastructural evaluation of isolated rat liver systems perfused with a hemoglobin-free medium. Journal of Biochemistry 1978; 83: 995–1007
   PubMed Web of Science ®Google Scholar
• Sugihara N, Furuno K, Kita N, Murakami T, Yata N. Distribution of quinidine in rats with carbon tetrachloride-intoxicated hepatic disease. Journal of Pharmacobio-dynamics 1992; 15: 167–174
   PubMedGoogle Scholar
• Tamura S, Ohike A, Tokunaga Y, Ibuki R, Amidon GL, Sezaki H, Yamashita S. Effect of experimental acute renal and hepatic failure on absorption of tacrolimus in rat small intestine. Drug Metabolism and Pharmacokinetics 2004; 3: 190–197
   Google Scholar
• Von Moltke LL, Greenblatt DJ, Cotreau BMM, Duan SX, Harmatz JS, Shader RI. Inhibition of desipramine hydroxylation in vitro by serotonin-reuptake-inhibitor antidepressants, and by quinidine and ketoconazole: A model system to predict drug interactions in vivo. Journal of Pharmacology and Experimental Therapeutics 1994; 268: 1278–1283
   PubMed Web of Science ®Google Scholar
• Wang HP, Li Y. Protective effect of bicyclol on acute hepatic failure induced by lipopolysaccharide and D-galactosamine in mice. European Journal of Pharmacology 2006; 534: 194–201
   PubMed Web of Science ®Google Scholar
• Wu CY, Benet LZ. Disposition of tacrolimus in isolated perfused rat liver: Influence of troleandomycin, cyclosporine, and gg918. Drug Metabolism and Disposition 2003; 31: 1292–1295
   PubMed Web of Science ®Google Scholar
• Yao GB, Xu DZh, Lan P, Xu ChB, Wang Ch, Luo J, Shen YM, Li Q. Efficacy and safety of bicyclol in treatment of 2,200 chronic viral hepatitis. Chinese Journal of New Drugs and Clinical Remedies 2005; 24: 421–426
   Google Scholar
• Yokogawa K, Watanabe M, Takeshita H, Nomura M, Mano Y, Miyamoto K. Serum aminotransferase activity as a predictor of clearance of drugs metabolized by CYP isoforms in rats with acute hepatic failure induced by carbon tetrachloride. International Journal of Pharmaceutics 2004; 269: 479–489
   PubMed Web of Science ®Google Scholar
• Zhang L, Lin G, Chang Q, Zuo Z. Role of intestinal first-pass metabolism of baicalein in its absorption process. Pharmaceutical Research 2005; 7: 1050–1058
   Google Scholar